PEPTIDES 2019 , ,
Presentations this author is a contributor to:
Validating the relaxin-3 neuropeptide receptor, RXFP3, as a promising target for the treatment of obesity and depression (#18)
9:00 AM
Craig Smith
New Targets / Discovery